CALA — Calithera Biosciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Calithera Biosciences Announces Update On Complete Liquidation And Dissolution
Brief: Calithera Biosciences Receives Notice Of Delisting Or Failure From Nasdaq
Calithera slumps as board approves company liquidation and dissolution
Brief: Calithera Biosciences Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Calithera Biosciences Inc Estimates That We Will Incur Charges Of About $8 Mln In Connection With The Reduction-In-Force
U.S. RESEARCH ROUNDUP-Calithera Biosciences, Haynes International, Lumos Pharma
Calithera Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: Calithera Biosciences Reports Third Quarter 2022 Financial Results
Calithera Biosciences Inc expected to post a loss of $1.93 a share - Earnings Preview
Calithera Biosciences Inc expected to post a loss of $1.93 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Silver miners, KBR, Regeneron
U.S. STOCKS ON THE MOVE-Coinbase, Peloton, Viasat
Calithera Biosciences up as FDA grants Fast Track designation to lung cancer therapy
Brief: Calithera Receives FDA Fast Track Designation For Sapanisertib
U.S. STOCKS ON THE MOVE-Envista, Bed Bath & Beyond, United Parcel Service
U.S. STOCKS ON THE MOVE-Astra Space, Ammo, Chimerix
Wainwright lifts Calithera to 'buy' over clinical program progress
Calithera Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Calithera Biosciences Reports Q2 2022 Results And Recent Highlights